Shares of UPL will remain in investors’ focus, as the company on Friday announced the acquisition of Arysta Life Science Inc for $4.2 billion. The acquisition will enhance its position as a global leader in the agriculture solutions market and will make it a $5-billion entity in combined sales. The all-cash deal agreement to acquire Arysta Life Science Inc and its subsidiaries is between UPL Corporation, the international arm of UPL, and NYSE-listed Platform Specialty Products Corporation.